title: [Cutaneous CD8+ T-cell lymphoma. Regression after HIV antiviral triple therapy].
authors: Servicio de Dermatología, Complejo Hospitalario de Navarra, Pamplona, Navarra, España. Electronic address: raquel.santesteban@hotmail.com.
authors: Raquel
authors: R
authors: Santesteban Muruzábal
authors: Servicio de Dermatología, Complejo Hospitalario de Navarra, Pamplona, Navarra, España.
authors: Josune
authors: J
authors: Mitxelena Ezeiza
authors: Servicio de Dermatología, Complejo Hospitalario de Navarra, Pamplona, Navarra, España.
authors: Alicia
authors: A
authors: Córdoba Iturriagagoitia
authors: Servicio de Dermatología, Complejo Hospitalario de Navarra, Pamplona, Navarra, España.
authors: Ignacio
authors: I
authors: Yanguas Bayona
mesh_terms: D000505:Alopecia / Q000188:drug therapy / Q000209:etiology; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D000069446:Atazanavir Sulfate / Q000627:therapeutic use; D018414:CD8-Positive T-Lymphocytes / Q000473:pathology; D002999:Clone Cells; D015224:Dideoxynucleosides / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D016130:Immunophenotyping; D019259:Lamivudine / Q000627:therapeutic use; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy* / Q000209:etiology; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D019438:Ritonavir / Q000627:therapeutic use; D000099227:Abacavir
chemical_list: D019380:Anti-HIV Agents; D000069446:Atazanavir Sulfate; D015224:Dideoxynucleosides; D019259:Lamivudine; D019438:Ritonavir; D000099227:Abacavir